Skip to main content
SpringerLink
Log in

Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials

  • Original Paper
  • Published:
International Orthopaedics Aims and scope Submit manuscript

Abstract

Whether selective cyclo-oxygenase-2 (COX-2) inhibitors are equally effective compared to nonselective NSAIDs for the prevention of heterotopic ossification (HO) after total hip arthroplasty (THA) is still unclear. We carried out a comprehensive search strategy, in which only randomised controlled trials were included. Two reviewers independently assessed methodological quality and extracted outcome data. Analyses were performed using Stata version 10.0. Four eligible randomised controlled trials totalling 808 patients were included. Meta-analysis results showed that no statistically significant difference was found in overall incidence of HO (RR 1.08; 95% CI 0.71–1.64), incidence of moderate severe HO (Brooker II and III) (RR 0.83; 95% CI 0.48–1.42) and any grade of Brooker classification between two groups. In summary, the selective COX-2 inhibitors are equally effective as nonselective NSAIDs for the prevention of HO after THA. Considering the gastrointestinal side effects of nonselective NSAIDs, we recommend selective COX-2 inhibitors for the prevention of HO after THA. However, future well-designed, randomised controlled trials are still needed to further confirm our results.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Guo JJ, Tang N, Yang HL, Qin L, Leung KS (2009) Impact of surgical approach on postoperative heterotopic ossification and avascular necrosis in femoral head fractures: a systematic review. Int Orthop. doi:10.1007/s00264-009-0849-3

    Google Scholar 

  2. Schmidt SA, Kjaersgaard-Andersen P, Pedersen NW, Kristensen SS, Pedersen P, Nielsen JB (1988) The use of indomethacin to prevent the formation of heterotopic bone after total hip replacement. A randomized, double-blind clinical trial. J Bone Jt Surg Am 70:834–838

    CAS  Google Scholar 

  3. Thomas BJ (1992) Heterotopic bone formation after total hip arthroplasty. Orthop Clin North Am 23:347–358

    PubMed  CAS  Google Scholar 

  4. Pakos EE, Pitouli EJ, Tsekeris PG, Papathanasopoulou V, Stafilas K, Xenakis TH (2006) Prevention of heterotopic ossification in high-risk patients with total hip arthroplasty: the experience of a combined therapeutic protocol. Int Orthop 30:79–83

    Article  PubMed  Google Scholar 

  5. Neal BC, Rodgers A, Clark T, Gray H, Reid IR, Dunn L, MacMahon SW (2000) A systematic survey of 13 randomized trials of non-steroidal anti-inflammatory drugs for the prevention of heterotopic bone formation after major hip surgery. Acta Orthop Scand 71:122–128

    Article  PubMed  CAS  Google Scholar 

  6. Rahme E, Barkun AN, Adam V, Bardou M (2004) Treatment costs to prevent or treat upper gastrointestinal adverse events associated with NSAIDs. Drug Saf 27:1019–1042

    Article  PubMed  Google Scholar 

  7. Barthel T, Baumann B, Noth U, Eulert J (2002) Prophylaxis of heterotopic ossification after total hip arthroplasty: a prospective randomized study comparing indomethacin and meloxicam. Acta Orthop Scand 73:611–614

    Article  PubMed  Google Scholar 

  8. Van der Heide HJ, Rijnberg WJ, Van Sorge A, Van Kampen A, Schreurs BW (2007) Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty. Acta Orthop 78:90–94

    Article  PubMed  Google Scholar 

  9. Grohs JG, Schmidt M, Wanivenhaus A (2007) Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: a double-blind randomized trial of 100 patients with 1-year follow-up. Acta Orthop 78:95–98

    Article  PubMed  Google Scholar 

  10. Saudan M, Saudan P, Perneger T, Riand N, Keller A, Hoffmeyer P (2007) Celecoxib versus ibuprofen in the prevention of heterotopic ossification following total hip replacement: a prospective randomised trial. J Bone Jt Surg Br 89:155–159

    CAS  Google Scholar 

  11. Brooker AF, Bowerman JW, Robinson RA, Riley LH Jr (1973) Ectopic ossification following total hip replacement. Incidence and a method of classification. J Bone Jt Surg Am 55:1629–1632

    CAS  Google Scholar 

  12. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF (1999) Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses. Lancet 354:1896–1900

    Article  PubMed  CAS  Google Scholar 

  13. Bradburn M, Deeks J, Altman D (1998) Sbe24: metan−an alternative meta-analysis command. Stata Tech Bull Reprints 8:86–100

    Google Scholar 

  14. Galbraith RF (1988) A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med 7:889–894

    Article  PubMed  CAS  Google Scholar 

  15. Cella JP, Salvati EA, Sculco TP (1988) Indomethacin for the prevention of heterotopic ossification following total hip arthroplasty. Effectiveness, contraindications, and adverse effects. J Arthroplast 3:229–234

    Article  CAS  Google Scholar 

  16. Hofmann S, Trnka HJ, Metzenroth H, Frank E, Ritschl P, Salzer M (1999) General short-term indomethacin prophylaxis to prevent heterotopic ossification in total hip arthroplasty. Orthopedics 22:207–211

    PubMed  CAS  Google Scholar 

  17. Van der Heide HJ, Koorevaar RT, Schreurs BW, van Kampen A, Lemmens A (1999) Indomethacin for 3 days is not effective as prophylaxis for heterotopic ossification after primary total hip arthroplasty. J Arthroplast 14:796–799

    Article  Google Scholar 

  18. Kristensen SS, Pedersen P, Pedersen NW, Schmidt SA, Kjaersgaard-Andersen P (1990) Combined treatment with indomethacin and low-dose heparin after total hip replacement. A double-blind placebo-controlled clinical trial. J Bone Jt Surg Br 72:447–449

    CAS  Google Scholar 

  19. Weber EW, Slappendel R, Durieux ME, Dirksen R, van der Heide H, Spruit M (2003) COX 2 selectivity of non-steroidal anti-inflammatory drugs and perioperative blood loss in hip surgery. A randomized comparison of indomethacin and meloxicam. Eur J Anaesthesiol 20:963–966

    Article  PubMed  CAS  Google Scholar 

  20. Goodman S, Ma T, Trindade M, Ikenoue T, Matsuura I, Wong N, Fox N, Genovese M, Regula D, Smith RL (2002) COX-2 selective NSAID decreases bone ingrowth in vivo. J Orthop Res 20:1164–1169

    Article  PubMed  CAS  Google Scholar 

  21. Simon AM, O’Connor JP (2007) Dose and time-dependent effects of cyclooxygenase-2 inhibition on fracture-healing. J Bone Jt Surg Am 89:500–511

    Article  Google Scholar 

  22. Van der Heide HJ, Hannink G, Buma P, Schreurs BW (2008) No effect of ketoprofen and meloxicam on bone graft ingrowth: a bone chamber study in goats. Acta Orthop 79:548–554

    Article  PubMed  Google Scholar 

  23. Wurnig C, Schwameis E, Bitzan P, Kainberger F (1999) Six-year results of a cementless stem with prophylaxis against heterotopic bone. Clin Orthop Relat Res 361:150–158

    Article  PubMed  Google Scholar 

  24. Bresalier RS, Sandler RS, Quan H, Bolognese JA, Oxenius B, Horgan K, Lines C, Riddell R, Morton D, Lanas A, Konstam MA, Baron JA (2005) Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 352:1092–1102

    Article  PubMed  CAS  Google Scholar 

  25. Cook DJ, Mulrow CD, Haynes RB (1997) Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med 126:376–380

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Orthopaedics, 2nd Affiliated Hospital, School of Medicine, Zhejiang University, #88 Jiefang Road, Hangzhou, 310009, Zhejiang, People’s Republic of China

    Deting Xue, Qiang Zheng, Hang Li, Shengjun Qian, Bo Zhang & Zhijun Pan

Authors
  1. Deting Xue
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Qiang Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shengjun Qian
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bo Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zhijun Pan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhijun Pan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xue, D., Zheng, Q., Li, H. et al. Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials. International Orthopaedics (SICOT) 35, 3–8 (2011). https://doi.org/10.1007/s00264-009-0886-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00264-009-0886-y

Keywords

Search

Navigation